NCT05570357View on ClinicalTrials.gov

Berberine and Cinnamon in Management of Diabetes

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

January 1, 2023

Study Completion Date

February 10, 2023

Conditions
Diabetes
Interventions
DIETARY_SUPPLEMENT

Berberine+Cinnamon (TDS)

The supplements contains 400 mg Berberine, and 200 mg Cinnamon extract

OTHER

Placebo (TDS)

Placebo contains Maltodexterin

Trial Locations (1)

19835

Azita Hekmatdoost, Tehran

All Listed Sponsors
lead

National Nutrition and Food Technology Institute

OTHER